H.R. 10223: End Tuberculosis Now Act of 2026

This bill would update U.S. foreign assistance law to make fighting tuberculosis (TB) a major priority of U.S. global health policy.

What it would do

• It would rewrite an existing section of the Foreign Assistance Act to focus more specifically on preventing, diagnosing, treating, and eliminating TB worldwide.
• It says the U.S. should support efforts to:
  • find TB cases earlier, including through active case finding and contact tracing;
  • treat adults and children with all forms of TB, including latent TB;
  • expand preventive treatment for people at high risk;
  • improve TB infection control in places like hospitals and prisons;
  • support better diagnostics, medicines, and vaccines;
  • reduce cost and supply barriers to TB care; and
  • help integrate TB services into primary health care systems where appropriate.
• It encourages the use of newer tools such as molecular diagnostics, telehealth solutions, and safer oral treatments.
• It directs U.S. programs to pay special attention to countries with the highest TB rates and to high-risk groups, including people with HIV, children, prisoners, migrants, miners, and people exposed to silica.

Goals and priorities

• The President would be directed to set goals for the period from January 1, 2027 through December 31, 2030 to:
  • reduce TB incidence by 80% from 2015 levels;
  • reduce TB deaths by 90% from 2015 levels;
  • diagnose and start treatment for 90% of new TB cases;
  • diagnose and start treatment for 90% of new drug-resistant TB cases;
  • achieve a 90% treatment success rate for both drug-sensitive and drug-resistant TB; and
  • provide TB preventive treatment to 30 million people.
• It also requires an update to the National Action Plan for Combating Multidrug-Resistant Tuberculosis.

How the U.S. would carry this out

• The bill authorizes the President to provide assistance for TB prevention, treatment, control, and elimination.
• It emphasizes coordination with:
  • partner countries;
  • international organizations;
  • nonprofit groups; and
  • the private sector.
• It also calls for coordination across U.S. agencies involved in international TB work, to reduce duplication and improve accountability.
• The bill supports sharing TB data and epidemiological information, helping high-TB countries strengthen local capacity, and using donor contributions more effectively.

Reporting and oversight

• The President would have to submit annual reports to Congress on U.S. TB assistance and its results until the goals are met or until December 31, 2032, whichever comes first.
• Those reports would cover items like:
  • numbers of people diagnosed and treated;
  • treatment completion rates;
  • training activities;
  • funding amounts and spending categories;
  • supply shortages or procurement problems;
  • coordination with partners and other agencies; and
  • country-level progress on prevention, diagnosis, and treatment.
• The bill would also require an annual report on TB research and development, including progress on diagnostics, treatments, telehealth, and vaccines.
• Within 4 years, the Comptroller General would have to evaluate how well U.S.-supported TB programs are working and recommend improvements.

Duration

• The new authority created by this bill would expire on January 1, 2033.

Relevant Companies

• None found